QUANTITATIVE DIGITAL PATHOLOGY SERVICES
IMAGE ANALYSIS SERVICES BY
RESEARCH PHASE
THERAPEUTIC AREA
TECHNOLOGY
OracleBio is a leading Contract Research Organisation (CRO) specialising in Quantitative Digital Pathology for Pharmaceutical and Biotechnology R&D
Studies Completed
Whole Slide Images (WSI) Analysed
Top Pharmaceutical Companies
By utilising industry-leading Image Analysis platforms – Visiopharm Oncotopix® and Indica Labs HALO® – we deliver expert histopathology image analysis services.
https://oraclebio.com/wp-content/uploads/2017/04/quality-blog.jpg 430 429 Hannah Thomson https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png Hannah Thomson2017-03-27 10:00:292017-04-21 09:25:42Quality Counts: Implementing Quality Standards as part of Image Analysis in Clinical R&D
https://oraclebio.com/wp-content/uploads/2017/02/immuno-oncology.jpg 428 428 Hannah Thomson https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png Hannah Thomson2017-02-02 10:34:092017-10-05 16:29:505 Ways Quantitative Histology Can Add Value to Immuno-Oncology R&D
https://oraclebio.com/wp-content/uploads/2015/04/tma-blog-title.jpg 430 430 John Waller https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png John Waller2015-04-30 16:55:262017-04-13 12:56:04Use of histology image analysis to aid selection of oncology xenograft models for drug development
https://oraclebio.com/wp-content/uploads/2014/06/microscope-slide-scanning-blog-title.jpg 429 429 John Waller https://oraclebio.com/wp-content/uploads/2019/09/OracleBio-Logo-Web-3.png John Waller2014-06-18 09:20:512017-04-13 12:58:02Microscope Slide Scanning
